{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T09:58:18Z","timestamp":1783504698531,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","journals.elsevierhealth.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.eururo.2014.06.012","type":"journal-article","created":{"date-parts":[[2014,6,27]],"date-time":"2014-06-27T15:00:31Z","timestamp":1403881231000},"page":"1024-1030","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"title":["Higher-than-expected Severe (Grade 3\u20134) Late Urinary Toxicity After Postprostatectomy Hypofractionated Radiotherapy: A Single-institution Analysis of 1176 Patients"],"prefix":"10.1016","volume":"66","author":[{"given":"Cesare","family":"Cozzarini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Fiorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Deantoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Fodor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"La Macchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Noris Chiorda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Maria Vittoria","family":"Rancoita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazareno","family":"Suardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Zerbetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Calandrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Di Muzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2014.06.012_bib0005","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijrobp.2007.06.042","article-title":"Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy","volume":"70","author":"Wong","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2014.06.012_bib0010","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.radonc.2008.03.021","article-title":"Hypofractionated adjuvant radiotherapy with helical TomoTherapy after radical prostatectomy: planning data and toxicity results of a phase I-II study","volume":"88","author":"Cozzarini","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.eururo.2014.06.012_bib0015","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1002\/cncr.25824","article-title":"Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence","volume":"117","author":"Kruser","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2014.06.012_bib0020","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijrobp.2007.10.008","article-title":"Radiotherapy after prostatectomy: is the evidence for dose escalation out there?","volume":"71","author":"King","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2014.06.012_bib0025","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.ijrobp.2009.02.049","article-title":"Salvage radiotherapy for rising prostate-specific antigen levels after radical prostatectomy for prostate cancer: dose-response analysis","volume":"76","author":"Bernard","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2014.06.012_bib0030","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ijrobp.2008.12.059","article-title":"Need for high radiation dose (>70Gy) in early postoperative irradiation after radical prostatectomy: a single-institution analysis of 334 high-risk, node-negative patients","volume":"75","author":"Cozzarini","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2014.06.012_bib0035","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1200\/JCO.2013.52.4942","article-title":"Prostate cancer and the hypofractionation hypothesis","volume":"31","author":"Lee","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2014.06.012_bib0040","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.eururo.2009.05.041","article-title":"Adjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy for prostate cancer: clinical results in 104 patients","volume":"56","author":"Ost","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.06.012_bib0045","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijrobp.2011.10.069","article-title":"The timing of salvage radiotherapy after radical prostatectomy: a systematic review","volume":"84","author":"King","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2014.06.012_bib0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijrobp.2007.09.047","article-title":"Improved outcomes with higher doses for salvage radiotherapy after prostatectomy","volume":"71","author":"King","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2014.06.012_bib0055","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/S0022-5347(01)66069-5","article-title":"Postoperative radiotherapy for stage pT3 carcinoma of the prostate: improved local control","volume":"155","author":"Syndikus","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2014.06.012_bib0060","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.clon.2004.07.006","article-title":"Hypofractionated radiotherapy as salvage for rising prostate-specific antigen after radical prostatectomy","volume":"16","author":"Lee","year":"2004","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.eururo.2014.06.012_bib0065","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/02841860410002824","article-title":"The radiobiology of prostate cancer including new aspects of fractionated radiotherapy","volume":"44","author":"Fowler","year":"2005","journal-title":"Acta Oncol"},{"key":"10.1016\/j.eururo.2014.06.012_bib0070","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ijrobp.2008.08.038","article-title":"Phase I-II study of hypofractionated simultaneous integrated boost with TomoTherapy for prostate cancer","volume":"74","author":"Di Muzio","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2014.06.012_bib0075","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0360-3016(02)04117-2","article-title":"Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6\u201370.2Gy)","volume":"55","author":"Cozzarini","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2014.06.012_bib0080","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.radonc.2007.07.013","article-title":"Significant reduction of acute toxicity following pelvic irradiation with helical TomoTherapy in patients with localized prostate cancer","volume":"84","author":"Cozzarini","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.eururo.2014.06.012_bib0085","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1080\/02841860802266755","article-title":"Physics aspects of prostate TomoTherapy: planning optimization and image-guidance issues","volume":"47","author":"Fiorino","year":"2008","journal-title":"Acta Oncol"},{"key":"10.1016\/j.eururo.2014.06.012_bib0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0360-3016(96)00468-3","article-title":"Late GI and GU complications in the treatment of prostate cancer","volume":"37","author":"Schultheiss","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2014.06.012_bib0095","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1200\/JCO.2005.06.153","article-title":"Randomized trial comparing two fractionation schedules for patients with localized prostate cancer","volume":"23","author":"Lukka","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2014.06.012_bib0100","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2007.04.049","article-title":"Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinoma","volume":"69","author":"Martin","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2014.06.012_bib0105","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.ijrobp.2006.10.050","article-title":"Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5Gy in five fractions for localized disease: first clinical trial results","volume":"67","author":"Madsen","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2014.06.012_bib0110","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.ijrobp.2007.01.067","article-title":"Hypofractionated intensity-modulated radiotherapy (70Gy at 2.5Gy per fraction) for localized prostate cancer: Cleveland Clinic experience","volume":"68","author":"Kupelian","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2014.06.012_bib0115","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijrobp.2007.09.004","article-title":"Combined hypofractionated radiation and hormone therapy for the treatment of intermediate-risk prostate cancer","volume":"71","author":"Yassa","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2014.06.012_bib0120","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.ijrobp.2010.07.1984","article-title":"Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: final results of phase III randomized trial","volume":"81","author":"Yeoh","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2014.06.012_bib0125","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ijrobp.2010.04.054","article-title":"A Phase II trial of arc-based hypofractionated intensity-modulated radiotherapy in localized prostate cancer","volume":"80","author":"Lock","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2014.06.012_bib0130","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijrobp.2010.05.057","article-title":"Twice-weekly hypofractionated intensity-modulated radiotherapy for localized prostate cancer with low-risk nodal involvement: toxicity and outcome from a dose escalation pilot study","volume":"81","author":"Zilli","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2014.06.012_bib0135","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ijrobp.2012.04.012","article-title":"Hypofractionated high-dose radiation therapy for prostate cancer: long-term results of a multi-institutional phase II trial","volume":"84","author":"Fonteyne","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2014.06.012_bib0140","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1200\/JCO.2013.51.1972","article-title":"Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer","volume":"31","author":"Pollack","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2014.06.012_bib0145","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.ijrobp.2013.07.041","article-title":"Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial","volume":"87","author":"Michalski","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2014.06.012_bib0150","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijrobp.2010.09.027","article-title":"Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: a single-institute analysis of 742 patients","volume":"82","author":"Cozzarini","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283814005338?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283814005338?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T02:23:24Z","timestamp":1538533404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283814005338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0302283814005338"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2014.06.012","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Higher-than-expected Severe (Grade 3\u20134) Late Urinary Toxicity After Postprostatectomy Hypofractionated Radiotherapy: A Single-institution Analysis of 1176 Patients","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2014.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}